Boston Scientific BSX-PA Stock
Boston Scientific Price Chart
Boston Scientific BSX-PA Financial and Trading Overview
Boston Scientific stock price | 122.18 USD |
Previous Close | 119.35 USD |
Open | 119.7 USD |
Bid | 47.96 USD x 1100 |
Ask | 0 USD x 1800 |
Day's Range | 119.7 - 123.27 USD |
52 Week Range | 97.37 - 129.12 USD |
Volume | 2.06M USD |
Avg. Volume | 191.49K USD |
Market Cap | N/A |
Beta (5Y Monthly) | 0.797325 |
PE Ratio (TTM) | 230.52832 |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | 5.5 (5.02%) |
Ex-Dividend Date | May 12, 2023 |
1y Target Est | N/A |
BSX-PA Valuation Measures
Enterprise Value | 184.71B USD |
Trailing P/E | 230.52832 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 9.839736 |
Enterprise Value/Revenue | 14.16 |
Enterprise Value/EBITDA | 56.297 |
Trading Information
Boston Scientific Stock Price History
Beta (5Y Monthly) | 0.797325 |
52-Week Change | 24.50% |
S&P500 52-Week Change | 20.43% |
52 Week High | 129.12 USD |
52 Week Low | 97.37 USD |
50-Day Moving Average | 123.43 USD |
200-Day Moving Average | 114.03 USD |
BSX-PA Share Statistics
Avg. Volume (3 month) | 191.49K USD |
Avg. Daily Volume (10-Days) | 424.53K USD |
Shares Outstanding | N/A |
Float | 1.43B |
Short Ratio | 0.03 |
% Held by Insiders | 0% |
% Held by Institutions | 90.57% |
Shares Short | 7.27K |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.91% |
Operating Margin (ttm) | 16.35% |
Gross Margin | 68.67% |
EBITDA Margin | 25.15% |
Management Effectiveness
Return on Assets (ttm) | 4.08% |
Return on Equity (ttm) | 5.17% |
Income Statement
Revenue (ttm) | 13.05B USD |
Revenue Per Share (ttm) | 9.11 USD |
Quarterly Revenue Growth (yoy) | 12.00% |
Gross Profit (ttm) | 8.68B USD |
EBITDA | 3.28B USD |
Net Income Avi to Common (ttm) | 846M USD |
Diluted EPS (ttm) | 0.53 |
Quarterly Earnings Growth (yoy) | 185.50% |
Balance Sheet
Total Cash (mrq) | 570M USD |
Total Cash Per Share (mrq) | 0.4 USD |
Total Debt (mrq) | 9.37B USD |
Total Debt/Equity (mrq) | 51.72 USD |
Current Ratio (mrq) | 1.397 |
Book Value Per Share (mrq) | 12.417 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.77B USD |
Levered Free Cash Flow (ttm) | 1.17B USD |
Profile of Boston Scientific
Country | United States |
State | MA |
City | Marlborough |
Address | 300 Boston Scientific Way |
ZIP | 01752-1234 |
Phone | 508 683 4000 |
Website | https://www.bostonscientific.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 45000 |
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Q&A For Boston Scientific Stock
What is a current BSX-PA stock price?
Boston Scientific BSX-PA stock price today per share is 122.18 USD.
How to purchase Boston Scientific stock?
You can buy BSX-PA shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Boston Scientific?
The stock symbol or ticker of Boston Scientific is BSX-PA.
Which industry does the Boston Scientific company belong to?
The Boston Scientific industry is Medical Devices.
How many shares does Boston Scientific have in circulation?
The max supply of Boston Scientific shares is 0.
What is Boston Scientific Price to Earnings Ratio (PE Ratio)?
Boston Scientific PE Ratio is 0.00000000 now.
What was Boston Scientific earnings per share over the trailing 12 months (TTM)?
Boston Scientific EPS is 0 USD over the trailing 12 months.
Which sector does the Boston Scientific company belong to?
The Boston Scientific sector is Healthcare.